{
    "2019-11-06": [
        [
            {
                "time": "2018-03-15",
                "original_text": "Teva earnings preview: Opioid suits are ‘key’",
                "features": {
                    "keywords": [
                        "Teva",
                        "earnings",
                        "opioid",
                        "suits",
                        "key"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2018-11-08",
                "original_text": "Theravance (TBPH) Q3 Loss In Line, Revenues Lag Estimates",
                "features": {
                    "keywords": [
                        "Theravance",
                        "Q3",
                        "Loss",
                        "Revenues",
                        "Lag",
                        "Estimates"
                    ],
                    "sentiment_score": -0.4,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "biotechnology"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            }
        ]
    ]
}